Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
1.330
+0.050 (3.91%)
At close: May 12, 2025, 4:00 PM
1.330
0.00 (-0.03%)
After-hours: May 12, 2025, 5:41 PM EDT
SONN Market Cap
SONN has a market cap or net worth of $4.08 million as of May 12, 2025. Its market cap has decreased by -28.00% in one year.
Market Cap
4.08M
Enterprise Value
-673.16K
1-Year Change
-28.00%
Ranking
Category
Stock Price
$1.33
Market Cap Chart
Since April 2, 2020, SONN's market cap has decreased from $58.10M to $4.08M, a decrease of -92.98%. That is a compound annual growth rate of -40.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 3.92M | -10.63% |
| Dec 31, 2024 | 4.39M | -17.79% |
| Dec 29, 2023 | 5.34M | -41.46% |
| Dec 30, 2022 | 9.12M | -63.34% |
| Dec 31, 2021 | 24.89M | -35.01% |
| Dec 31, 2020 | 38.30M | -34.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |